Nam Doo Kim

4.7k total citations
102 papers, 2.9k citations indexed

About

Nam Doo Kim is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Nam Doo Kim has authored 102 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 24 papers in Oncology and 15 papers in Organic Chemistry. Recurrent topics in Nam Doo Kim's work include Cancer-related Molecular Pathways (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and NF-κB Signaling Pathways (7 papers). Nam Doo Kim is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and NF-κB Signaling Pathways (7 papers). Nam Doo Kim collaborates with scholars based in South Korea, United States and China. Nam Doo Kim's co-authors include Taebo Sim, Kyun‐Hwan Kim, Baik Lin Seong, Joo Young Lee, Nathanael S. Gray, Hwan Geun Choi, Pasi A. Jänne, Jarrod A. Marto, Scott B. Ficarro and Jeong Hyeok Yoon and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Nam Doo Kim

99 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nam Doo Kim South Korea 32 1.8k 454 384 277 274 102 2.9k
Rozbeh Jafari Sweden 9 2.6k 1.5× 340 0.7× 527 1.4× 267 1.0× 268 1.0× 25 3.6k
Marina Ignatushchenko United States 9 1.9k 1.1× 304 0.7× 440 1.1× 206 0.7× 236 0.9× 10 2.9k
Michael G. Malkowski United States 33 1.4k 0.8× 630 1.4× 335 0.9× 218 0.8× 213 0.8× 75 3.5k
Philip Reigan United States 31 2.0k 1.1× 373 0.8× 677 1.8× 364 1.3× 237 0.9× 78 3.0k
Yu‐Sheng Chao Taiwan 36 1.6k 0.9× 533 1.2× 541 1.4× 357 1.3× 454 1.7× 98 3.7k
Minghai Tang China 32 1.9k 1.0× 636 1.4× 468 1.2× 220 0.8× 224 0.8× 151 3.2k
Hong Seok Choi South Korea 30 1.6k 0.9× 299 0.7× 522 1.4× 256 0.9× 422 1.5× 88 2.6k
Parvez Κhan India 33 1.6k 0.9× 618 1.4× 523 1.4× 198 0.7× 141 0.5× 85 2.9k
Mee‐Hyun Lee South Korea 33 2.4k 1.4× 356 0.8× 739 1.9× 546 2.0× 350 1.3× 130 3.8k
Mohane Selvaraj Coumar India 27 1.2k 0.7× 577 1.3× 511 1.3× 147 0.5× 118 0.4× 96 2.3k

Countries citing papers authored by Nam Doo Kim

Since Specialization
Citations

This map shows the geographic impact of Nam Doo Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nam Doo Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nam Doo Kim more than expected).

Fields of papers citing papers by Nam Doo Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nam Doo Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nam Doo Kim. The network helps show where Nam Doo Kim may publish in the future.

Co-authorship network of co-authors of Nam Doo Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Nam Doo Kim. A scholar is included among the top collaborators of Nam Doo Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nam Doo Kim. Nam Doo Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sung, Yulseung, Ya Chun Yu, Mirim Lee, et al.. (2025). Targeting cancer glutamine dependency with a first-in-class inhibitor of the mitochondrial glutamine transporter SLC1A5_var. Nature Communications. 16(1). 9690–9690.
2.
Jeon, Yong Geun, Chang Yeob Han, Jae Do Yang, et al.. (2024). p21-activated kinase 4 counteracts PKA-dependent lipolysis by phosphorylating FABP4 and HSL. Nature Metabolism. 6(1). 94–112. 15 indexed citations
3.
Kim, Nam Doo, et al.. (2023). Identification of α-amanitin effector proteins in hepatocytes by limited proteolysis-coupled mass spectrometry. Chemico-Biological Interactions. 386. 110778–110778. 5 indexed citations
4.
Lee, Gi Ho, Sun Woo Jin, Seung Yeon Lee, et al.. (2023). Sesamin ameliorates lipotoxicity and lipid accumulation through the activation of the estrogen receptor alpha signaling pathway. Biochemical Pharmacology. 216. 115768–115768. 20 indexed citations
5.
6.
Park, Jung‐Hyun, Jin‐Young Min, Jae‐Young Kim, et al.. (2021). A Novel Protein–Protein Interaction between RSK3 and IκBα and a New Binding Inhibitor That Suppresses Breast Cancer Tumorigenesis. Cancers. 13(12). 2973–2973. 8 indexed citations
7.
Shin, Injae, et al.. (2020). The first small molecules capable of strongly suppressing proliferation of cancer cells harboring BRAF class I/II/III mutations. Biochemical and Biophysical Research Communications. 532(2). 315–320. 7 indexed citations
8.
Sengupta, Sandip, Byung Joo Lee, Hanna Cho, et al.. (2019). Identification of a Unique Resorcylic Acid Lactone Derivative That Targets Both Lymphangiogenesis and Angiogenesis. Journal of Medicinal Chemistry. 62(20). 9141–9160. 9 indexed citations
9.
10.
Bahcall, Magda, Taebo Sim, Cloud P. Paweletz, et al.. (2016). Acquired MET D1228V Mutation and Resistance to MET Inhibition in Lung Cancer. Cancer Discovery. 6(12). 1334–1341. 114 indexed citations
11.
Shin, Woo-Jin, et al.. (2016). Identification of a Small Benzamide Inhibitor of Influenza Virus Using a Cell-Based Screening. Chemotherapy. 61(3). 159–166. 5 indexed citations
12.
Kim, Young Hye, Sung Woo Kim, Yong Ju Lee, et al.. (2016). A bioorthogonal approach for imaging the binding between Dasatinib and its target proteins inside living cells. Chemical Communications. 52(79). 11764–11767. 7 indexed citations
13.
Ko, Sung‐Kyun, Jiyeon Kim, Seong‐Hyun Park, et al.. (2015). A Small Molecule Inhibitor of ATPase Activity of HSP70 Induces Apoptosis and Has Antitumor Activities. Chemistry & Biology. 22(3). 391–403. 92 indexed citations
14.
Yoon, Hojong, et al.. (2015). A Pyrazolo[3,4-d]pyrimidin-4-amine Derivative Containing an Isoxazole Moiety Is a Selective and Potent Inhibitor of RET Gatekeeper Mutants. Journal of Medicinal Chemistry. 59(1). 358–373. 28 indexed citations
15.
Karki, Radha, Tara Man Kadayat, Eun‐Young Lee, et al.. (2012). Design, synthesis, and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety. European Journal of Medicinal Chemistry. 52. 123–136. 58 indexed citations
16.
Roh, Eunmiri, Ji Young Yun, Dongsun Park, et al.. (2012). cAMP-Binding Site of PKA as a Molecular Target of Bisabolangelone against Melanocyte-Specific Hyperpigmented Disorder. Journal of Investigative Dermatology. 133(4). 1072–1079. 31 indexed citations
17.
Kim, Nam Doo, et al.. (2011). Discovery of novel HCV polymerase inhibitors using pharmacophore-based virtual screening. Bioorganic & Medicinal Chemistry Letters. 21(11). 3329–3334. 8 indexed citations
18.
Jung, Hye Jin, Joong Sup Shim, Jiyong Lee, et al.. (2010). Terpestacin Inhibits Tumor Angiogenesis by Targeting UQCRB of Mitochondrial Complex III and Suppressing Hypoxia-induced Reactive Oxygen Species Production and Cellular Oxygen Sensing. Journal of Biological Chemistry. 285(15). 11584–11595. 101 indexed citations
19.
Lee, Yong-Wha, Dong Hwan Lee, Jerry Vockley, et al.. (2007). Different spectrum of mutations of isovaleryl-CoA dehydrogenase (IVD) gene in Korean patients with isovaleric acidemia. Molecular Genetics and Metabolism. 92(1-2). 71–77. 26 indexed citations
20.
Kim, Nam Doo, et al.. (1992). Theoretical Studies of 1,5-Sigmatropic Rearrangements Involving Group Transfer$^1$. Bulletin of the Korean Chemical Society. 13(5). 565–570. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rozbeh Jafari Breakdown of academic impact, for papers by Marina Ignatushchenko Breakdown of academic impact, for papers by Michael G. Malkowski Breakdown of academic impact, for papers by Philip Reigan Breakdown of academic impact, for papers by Yu‐Sheng Chao Breakdown of academic impact, for papers by Minghai Tang Breakdown of academic impact, for papers by Hong Seok Choi Breakdown of academic impact, for papers by Parvez Κhan Breakdown of academic impact, for papers by Mee‐Hyun Lee Breakdown of academic impact, for papers by Mohane Selvaraj Coumar
Rankless by CCL
2026